Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

Autor: Ackerman, Stacey L., Alpern, Louis M., Asrani, Sanjay, Bashford, Kent, Bluestein, Ettaleah C., Boyce, James D., Branch, James D., Brubaker, Jacob W., Christie, William C., Cohen, John S., Collins, Nicole M., Corin, Scott M., Daynes, Todd Ellsworth, Depenbusch, Michael, Dixon, El-Roy, Duzman, Eran, Flowers, Brian E., Flynn, William J., Fong, Raymond, Gira, Joseph P., Goldberg, Damien F., Greene, Brennan, Han, Scott B., Henderson, Thomas T., Jerkins, Gary, Jong, Kevin Y., Katzen, Lawrence B., Khemsara, Vickas, Klugo, Karen L., Kozlovsky, John F., Leonardo, Donna, Liu, Yao, LoBue, Thomas D., Luchs, Jodi Ian, Malhotra, Ranjan P., Mays, Andrew, McLaurin, Eugene B., McMenemy, Matthew G., Modi, Satish, Moroi, Sayoko, Mulaney, Jay, Nagi, Kundandeep, Nicolau, John, Parikh, Mihir, Patel, Jay R., Peplinski, Lee S., Perez, Bernard R., Piltz-Seymour, Jody, Sadri, Ehsan, Saltzmann, Robert M., Schenker, Howard I., Swanic, Matthew J., Tekwani, Navin, Teymoorian, Savak, Thomas, Justus W., Tyson, Farrell C., Vold, Stephen, Weiss, Mark J., Zaman, Fiaz, Robin, Alan L., Serle, Janet B., Lewis, Richard A., Usner, Dale W., Kopczynski, Casey C., Heah, Theresa

Publikováno v: In American Journal of Ophthalmology November 2019 207:248-257